NCT06092424View on ClinicalTrials.gov

High Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA)

NAActive, not recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 23, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions
Pulmonary Vascular DiseasePulmonary Arterial HypertensionChronic Thromboembolic Pulmonary Hypertension
Interventions
BEHAVIORAL

Relocation from HA to LA

Patients will be relocated by bus from Quito (2840m) to Pedernales (sea level) and have investigations at both altitudes

Trial Locations (1)

8091

Respiratory Clinic, University Hospital of Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT06092424 - High Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA) | Biotech Hunter | Biotech Hunter